Natalia Karamyan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Natalia Karamyan has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Svetlana Mann
Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology, Ministry of Healthcare, Samora Machel Street, 1, GSP-7, Moscow 117198, Russia
4 shared publications - Alexander V. Poletaev
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia
2 shared publications - Alexey V. Pshonkin
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia
2 shared publications - Daria V. Fedorova
The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Health of the Russian Federation
2 shared publications - Elena A. Seregina
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia
2 shared publications - Evgeny Litvin
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
2 shared publications
Latest Publications
- Open Access
- 29 January 2026
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 24 (4) , 166-171
Co-inheritance of β-thalassemia and hereditary spherocytosis in one family
Introduction. The co-inheritance of β-thalassemia and hereditary spherocytosis is a rare clinical phenomenon that complicates diagnosis due to confounding laboratory and clinical presentations. Clinical case. This case report describes a family with β-thalassemia in the mother and hereditary spherocytosis in the father. The daughter inherited β-thalassemia, while the son with moderate anemia, splenomegaly, and hyperbilirubinemia co-inherited a mutation in the HBB gene (β-thalassemia) from the mother and a mutation in the SPTB gene (hereditary spherocytosis) from the father which was confirmed by NGS. The son presented with some characteristics that did not fit the typical diagnostic criteria: paradoxical results of osmotic fragility test alongside the typical features of both diseases (microcytosis, elevated HbA2/HbF, reduced sphericity index). After splenectomy, his hematological parameters improved; however, the presence of mild anemia indicates the persisting influence of thalassemia. Conclusion. This case highlights the necessity of comprehensive genetic testing in patients with atypical course of hemolytic anemia.
- 29 January 2026
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 24 (4) , 166-171
Open AccessCo-inheritance of β-thalassemia and hereditary spherocytosis in one family
Introduction. The co-inheritance of β-thalassemia and hereditary spherocytosis is a rare clinical phenomenon that complicates diagnosis due to confounding laboratory and clinical presentations. Clinical case. This case report describes a family with β-thalassemia in the mother and hereditary spherocytosis in the father. The daughter inherited β-thalassemia, while the son with moderate anemia, splenomegaly, and hyperbilirubinemia co-inherited a mutation in the HBB gene (β-thalassemia) from the mother and a mutation in the SPTB gene (hereditary spherocytosis) from the father which was confirmed by NGS. The son presented with some characteristics that did not fit the typical diagnostic criteria: paradoxical results of osmotic fragility test alongside the typical features of both diseases (microcytosis, elevated HbA2/HbF, reduced sphericity index). After splenectomy, his hematological parameters improved; however, the presence of mild anemia indicates the persisting influence of thalassemia. Conclusion. This case highlights the necessity of comprehensive genetic testing in patients with atypical course of hemolytic anemia.
- 28 February 2025
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 104 (1)
Russia’s first identified case of abnormal Hemoglobin Kansas with low oxygen affinity, a rare cause of cyanosis
Diagnosis of rare causes of cyanosis is if a certain difficulty. A clinical case report of cyanosis caused by the presence of abnormal Hemoglobin (Hb) Kansas with reduced oxygen affinity is presented. This is the Russia’s first detected and recorded case in a Russian child with cyanosis and mild anemia. As a result of routine examination using capillary electrophoresis and high-performance liquid chromatography, a pathological fraction of Hb was detected. Molecular genetic research according to Sanger determined a mutation in codon 102 of the β-globin gene with the replacement of aspartic acid with threonine, corresponding to rare abnormal Hb Kansas with reduced oxygen affinity.
- 28 February 2025
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 104 (1)
Russia’s first identified case of abnormal Hemoglobin Kansas with low oxygen affinity, a rare cause of cyanosis
Diagnosis of rare causes of cyanosis is if a certain difficulty. A clinical case report of cyanosis caused by the presence of abnormal Hemoglobin (Hb) Kansas with reduced oxygen affinity is presented. This is the Russia’s first detected and recorded case in a Russian child with cyanosis and mild anemia. As a result of routine examination using capillary electrophoresis and high-performance liquid chromatography, a pathological fraction of Hb was detected. Molecular genetic research according to Sanger determined a mutation in codon 102 of the β-globin gene with the replacement of aspartic acid with threonine, corresponding to rare abnormal Hb Kansas with reduced oxygen affinity.
- 4 March 2023
- Published by Taylor & Francis in Hemoglobin
- Vol. 47 (2) , 97-101
Hb Ryazan: An Elongated C‐Terminal β-Chain Due to a New Frameshift Mutation, HBB: c.396delG p.Val133Trpfs*25
We identified a novel abnormal hemoglobin variant caused by a frameshift mutation at nucleotide position 396 in exon 3 of the β-globin gene (HBB): NM_000518:c.396delG. This variant causes an emergence of alternative amino acid sequence starting at codon 133 and a new stop codon formed in the 3' untranslated region (3'UTR) of the HBB gene at amino acid position 158. This β-globin gene variant was identified in a woman with a long history of hemolytic anemia. We named this variant Hb Ryazan after the proband's city of origin.
- 4 March 2023
- Published by Taylor & Francis in Hemoglobin
- Vol. 47 (2) , 97-101
Hb Ryazan: An Elongated C‐Terminal β-Chain Due to a New Frameshift Mutation, HBB: c.396delG p.Val133Trpfs*25
We identified a novel abnormal hemoglobin variant caused by a frameshift mutation at nucleotide position 396 in exon 3 of the β-globin gene (HBB): NM_000518:c.396delG. This variant causes an emergence of alternative amino acid sequence starting at codon 133 and a new stop codon formed in the 3' untranslated region (3'UTR) of the HBB gene at amino acid position 158. This β-globin gene variant was identified in a woman with a long history of hemolytic anemia. We named this variant Hb Ryazan after the proband's city of origin.
- Open Access
- 8 October 2021
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 20 (3) , 102-107
First cases of Hb Lepore in the Russian Federation
Hb Lepore, as the result of fusion of the b- and d-globin genes, leads to decreased amount of non-a-globin chains availability for hemoglobin formation. Hb Lepore, up to now, was not identified among Russian patients. We provide clinical and laboratory information on Hb Lepore Boston–Washington in two cases, one of them familial. A small amount of abnormal Hb was detected by capillary electrophoresis, an abnormal globin chain was shown by HPLC, and the final diagnosis of Hb Lepore Boston– Washington was made by molecular biological analysis of globin genes. Peripheral blood for all affected people revealed RBC’s hypochromia microcytosis and normal Hb concentration. The parents of the patients agreed to use the information, including photos of children, in scientific research and publications.
- 8 October 2021
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 20 (3) , 102-107
Open AccessFirst cases of Hb Lepore in the Russian Federation
Hb Lepore, as the result of fusion of the b- and d-globin genes, leads to decreased amount of non-a-globin chains availability for hemoglobin formation. Hb Lepore, up to now, was not identified among Russian patients. We provide clinical and laboratory information on Hb Lepore Boston–Washington in two cases, one of them familial. A small amount of abnormal Hb was detected by capillary electrophoresis, an abnormal globin chain was shown by HPLC, and the final diagnosis of Hb Lepore Boston– Washington was made by molecular biological analysis of globin genes. Peripheral blood for all affected people revealed RBC’s hypochromia microcytosis and normal Hb concentration. The parents of the patients agreed to use the information, including photos of children, in scientific research and publications.
- Open Access
- 12 July 2021
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 8 (2) , 35-41
Von Willebrand factor multimeric assay: novel diagnostics capabilities
Introduction. Distinguishing between Von Willebrand disease (vWD) types often requires multimer gel analysis. The current techniques for vWF multimer structure are manual, complicated, non-standardized and time consuming. The aim of this study was to evaluate diagnostic capabilities of new automated vWF multimer screening assay.Materials and methods. Children with vWD, acquired von Willebrand Syndrome (aVWS) and 8 healthy donors as a control group were enrolled in this study. Von Willebrand factor antigen (vWF Ag); ristocetin cofactor activity (VWF:Rco); vWF collagen binding (VWF:CB); ristocetin-induced platelet aggregation (RIPA); factor VIII clotting activity (FVIII:C) and vWF factor VIII binding activity (vWF:FVIIIb) were performed to evaluate vWD. Multimer analysis was carried out using the commercial HYDRAGEL 5 von Willebrand Multimers kit on semi-automatic gel electrophoresis instrument HYDRASYS (SEBIA).Results. The samples from control group had 9—12 bands of vWF multimers with the same distribution as control plasma. Patients with type I vWD had the proportional decrease in the intensity of the bands with preservation of the normal distribution of the band. Patients with type III vWD reveal the complete absence of the multimer bands on the gel. Multimer analysis in type IIA shows the absence of high molecular weight multimer bands. In other patients the distribution of vWF multimers was normal against the changes in functional properties of vWF (types IIM, N). Most of the children with aVWS also revealed normal distribution of vWF multimers, however, in some patients, the slight decrease in large multimeric forms was observed visually on the gel.Conclusion. Multimer analysis allows to visualize the multimer distribution in various types of von Willebrand disease. The method is easy to perform and can be useful for distinguishing between the subtypes of vWD. But only the full test panel including genetic tests would allow the differentiantion of vWD types with high precision.
- 12 July 2021
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 8 (2) , 35-41
Open AccessVon Willebrand factor multimeric assay: novel diagnostics capabilities
Introduction. Distinguishing between Von Willebrand disease (vWD) types often requires multimer gel analysis. The current techniques for vWF multimer structure are manual, complicated, non-standardized and time consuming. The aim of this study was to evaluate diagnostic capabilities of new automated vWF multimer screening assay.Materials and methods. Children with vWD, acquired von Willebrand Syndrome (aVWS) and 8 healthy donors as a control group were enrolled in this study. Von Willebrand factor antigen (vWF Ag); ristocetin cofactor activity (VWF:Rco); vWF collagen binding (VWF:CB); ristocetin-induced platelet aggregation (RIPA); factor VIII clotting activity (FVIII:C) and vWF factor VIII binding activity (vWF:FVIIIb) were performed to evaluate vWD. Multimer analysis was carried out using the commercial HYDRAGEL 5 von Willebrand Multimers kit on semi-automatic gel electrophoresis instrument HYDRASYS (SEBIA).Results. The samples from control group had 9—12 bands of vWF multimers with the same distribution as control plasma. Patients with type I vWD had the proportional decrease in the intensity of the bands with preservation of the normal distribution of the band. Patients with type III vWD reveal the complete absence of the multimer bands on the gel. Multimer analysis in type IIA shows the absence of high molecular weight multimer bands. In other patients the distribution of vWF multimers was normal against the changes in functional properties of vWF (types IIM, N). Most of the children with aVWS also revealed normal distribution of vWF multimers, however, in some patients, the slight decrease in large multimeric forms was observed visually on the gel.Conclusion. Multimer analysis allows to visualize the multimer distribution in various types of von Willebrand disease. The method is easy to perform and can be useful for distinguishing between the subtypes of vWD. But only the full test panel including genetic tests would allow the differentiantion of vWD types with high precision.
- Open Access
- 22 November 2020
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 19 (4) , 102-106
Results of extended phenotyping of von Willebrand disease in the remote diagnostic program in children
In the course of our earlier data obtained in remote diagnosis of von Willebrand disease (vWD) program, 16 samples were identified for extended laboratory work up in order to clarify a specific subtype of vWD. Purpose of the study: extended phenotyping of blood samples with suspected type 2 vWD. This study is supported by the Independent Ethics Committee and approved by the Academic Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology. Using 16 aliquoted frozen samples, collagen-binding (vWF:CB) and fVIII-binding activity of vWF (vWF:FVIIIB) tests were performed, as well as multimeric analysis of vWF. Isolated fVIII deficiency with no laboratory signs of 2N vWD subtype were detected in 7 (44%) of 16 patients with an initial decrease in the ratio of fVIII activity to vWF antigen. In the remaining 9 patients, vWF:CB was assessed, which showed a decrease in association with collagen in 6 patients, which allows one to suspect type 2A or 2B. In the remaining 3 with normal vWF:CB patients, type 2M was suspected. MA helped to further identify patients with suspected type 2B vWD. The use of remote diagnostics technologies allows phenotyping most forms of vWD even in patients living in regions with limited laboratory capabilities.
- 22 November 2020
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 19 (4) , 102-106
Open AccessResults of extended phenotyping of von Willebrand disease in the remote diagnostic program in children
In the course of our earlier data obtained in remote diagnosis of von Willebrand disease (vWD) program, 16 samples were identified for extended laboratory work up in order to clarify a specific subtype of vWD. Purpose of the study: extended phenotyping of blood samples with suspected type 2 vWD. This study is supported by the Independent Ethics Committee and approved by the Academic Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology. Using 16 aliquoted frozen samples, collagen-binding (vWF:CB) and fVIII-binding activity of vWF (vWF:FVIIIB) tests were performed, as well as multimeric analysis of vWF. Isolated fVIII deficiency with no laboratory signs of 2N vWD subtype were detected in 7 (44%) of 16 patients with an initial decrease in the ratio of fVIII activity to vWF antigen. In the remaining 9 patients, vWF:CB was assessed, which showed a decrease in association with collagen in 6 patients, which allows one to suspect type 2A or 2B. In the remaining 3 with normal vWF:CB patients, type 2M was suspected. MA helped to further identify patients with suspected type 2B vWD. The use of remote diagnostics technologies allows phenotyping most forms of vWD even in patients living in regions with limited laboratory capabilities.